ROSSARI2024-10-012024-12-31 ROSSARI2024-10-012024-12-31 ROSSARI2024-10-012024-12-31in-bse-fin:OneOperatingExpenses01Member ROSSARI2024-10-012024-12-31in-bse-fin:FourOperatingExpenses01Member ROSSARI2024-12-31 iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 543213 ROSSARI NOTLISTED Rossari Biotech Limited Equity 2024-04-01 2025-03-31 2025-01-21 2025-01-13 INR Millions Third quarter 17:30:00 18:45:00 2025-01-21 2025-01-21 Not applicable Single segment Manufacturing of Specialty Chemicals for Textile, Home and Personal Care, Performance Chemicals and Animal Health and Nutrition industries 2024-10-01 2024-12-31 Unaudited Standalone 3682780000.00 10060000.00 3692840000.00 2098050000.00 577390000.00 -13080000.00 163630000.00 22780000.00 74260000.00 357190000.00 3280220000.00 412620000.00 0.00 412620000.00 114740000.00 -8430000.00 106310000.00 0.00 306310000.00 0.00 0.00 0.00 0.00 306310000.00 -30000.00 306280000.00 0.00 0.00 110710000.00 2 5.53 5.53 0.00 0.00 5.53 5.53 Notes:1.The financial results have been reviewed and recommended by the Audit Committee and approved by the Board of Directors at their meeting held on 21st January, 2025.2.The standalone financial results have been prepared in accordance with the recognition and measurement principles laid down under Indian Accounting Standard (Ind AS) 34, Interim Financial Reporting as prescribed under Section 133 of the Companies Act, 2013 read with relevant rules issued thereunder and other accounting principles generally accepted in India in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended.3.The Company deals in Specialty chemicals and considering that the nature of products and the predominant risk and returns of the products are similar, the Company considers it as one operating segment.4.During the quarter ended 31st December, 2024, the Company has incorporated a wholly owned subsidiary 'Rossari International Limited Company' in Kingdom of Saudi Arabia w.e.f. 24th December, 2024.5.During the quarter ended 31st December, 2024, the Company has allotted 67,000 equity shares of Rs. 2.00 each pursuant to exercise of options under the approved Rossari Employee Stock Option Plan - 2019. 6.Previous year/period figures have been regrouped to make them comparable with the current year / period figures, which are not material. For ROSSARI BIOTECH LIMITED EDWARD MENEZES Executive Chairman DIN:00149205 Place : Mumbai Date : 21st January,2025 Single segment 2024-04-01 2024-12-31 Unaudited Standalone 10049750000.00 33460000.00 10083210000.00 5524450000.00 1911790000.00 -123650000.00 442490000.00 65090000.00 200270000.00 954320000.00 8974760000.00 1108450000.00 0.00 1108450000.00 298350000.00 -13680000.00 284670000.00 0.00 823780000.00 0.00 0.00 0.00 0.00 823780000.00 -90000.00 823690000.00 0.00 0.00 110710000.00 2 14.90 14.88 0.00 0.00 14.90 14.88 Other Expenses 357190000.00 Other Expenses 954320000.00 -40000.00 -120000.00 -10000.00 -30000.00